Abstract
The study of in vitro infections is essential to evaluate distinct aspects of Leishmania biology and also invaluable for more meaningful in vitro screening of promising chemical entities. Macrophage-like cells lines from different origins are amenable to Leishmania infection. Cell lines due to their stability and standardization potential are highly valued for their capacity to support reproducible infections and consistent data. In fact, these cells have been a mainstay of leishmaniasis research for more than 40 years. In this context, the human monocytic THP-1 cell line is commonly used as it can be differentiated with phorbol-12myristate-13-acetate (PMA) into macrophages that are susceptible to Leishmania infection. In this section, we will describe generalities concerning the use of cell lines for in vitro Leishmania infection using THP-1 derived macrophages and Leishmania infantum axenic amastigotes expressing luciferase associated to preclinical drug screening as example.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO (2017) Leishmaniasis. http://www.who.int/leishmaniasis/en/. Accessed 30 Nov 2017.
Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12(4):207–218. https://doi.org/10.1089/adt.2014.573
Zulfiqar B, Shelper TB, Avery VM (2017) Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discov Today 22(10):1516–1531. https://doi.org/10.1016/j.drudis.2017.06.004
De Muylder G, Ang KK, Chen S, Arkin MR, Engel JC, McKerrow JH (2011) A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl Trop Dis 5(7):e1253. https://doi.org/10.1371/journal.pntd.0001253
Nuhs A, De Rycker M, Manthri S, Comer E, Scherer CA, Schreiber SL, Ioset JR, Gray DW (2015) Development and validation of a novel Leishmania donovani screening cascade for high-throughput screening using a novel axenic assay with high predictivity of leishmanicidal intracellular activity. PLoS Negl Trop Dis 9(9):e0004094. https://doi.org/10.1371/journal.pntd.0004094
Shafi S, Afrin F, Islamuddin M, Chouhan G, Ali I, Naaz F, Sharma K, Zaman MS (2016) Beta-nitrostyrenes as potential anti-leishmanial agents. Front Microbiol 7:1379. https://doi.org/10.3389/fmicb.2016.01379
Santarem N, Cunha J, Silvestre R, Silva C, Moreira D, Ouellette M, Cordeiro-da-Silva A (2014) The impact of distinct culture media in Leishmania infantum biology and infectivity. Parasitology 141(2):192–205. https://doi.org/10.1017/S0031182013001388
Maia C, Rolao N, Nunes M, Goncalves L, Campino L (2007) Infectivity of five different types of macrophages by Leishmania infantum. Acta Trop 103(2):150–155. https://doi.org/10.1016/j.actatropica.2007.06.001
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26(2):171–176
Ogunkolade BW, Colomb-Valet I, Monjour L, Rhodes-Feuillette A, Abita JP, Frommel D (1990) Interactions between the human monocytic leukaemia THP-1 cell line and Old and New World species of Leishmania. Acta Trop 47(3):171–176
Sundstrom C, Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17(5):565–577
Gupta S, Yardley V, Vishwakarma P, Shivahare R, Sharma B, Launay D, Martin D, Puri SK (2015) Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis. J Antimicrob Chemother 70(2):518–527. https://doi.org/10.1093/jac/dku422
Ralph P, Moore MA, Nilsson K (1976) Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med 143(6):1528–1533
Pratt DM, David JR (1982) Monoclonal antibodies recognizing determinants specific for the promastigote state of Leishmania mexicana. Mol Biochem Parasitol 6(5):317–327
Kolodziej H, Kiderlen AF (2005) Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells. Phytochemistry 66(17):2056–2071. https://doi.org/10.1016/j.phytochem.2005.01.011
Raschke WC, Baird S, Ralph P, Nakoinz I (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15(1):261–267
Nandan D, Lo R, Reiner NE (1999) Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 67(8):4055–4063
Wellman ML, Krakowka S, Jacobs RM, Kociba GJ (1988) A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol 24(3):223–229
Looker DL, Martinez S, Horton JM, Marr JJ (1986) Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism. J Infect Dis 154(2):323–327
Lund ME, To J, O'Brien BA, Donnelly S (2016) The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. J Immunol Methods 430:64–70. https://doi.org/10.1016/j.jim.2016.01.012
Borsari C, Santarem N, Torrado J, Olias AI, Corral MJ, Baptista C, Gul S, Wolf M, Kuzikov M, Ellinger B, Witt G, Gribbon P, Reinshagen J, Linciano P, Tait A, Costantino L, Freitas-Junior LH, Moraes CB, Bruno Dos Santos P, Alcantara LM, Franco CH, Bertolacini CD, Fontana V, Tejera Nevado P, Clos J, Alunda JM, Cordeiro-da-Silva A, Ferrari S, Costi MP (2017) Methoxylated 2′-hydroxychalcones as antiparasitic hit compounds. Eur J Med Chem 126:1129–1135. https://doi.org/10.1016/j.ejmech.2016.12.017
ATCC THP1(ATCC TIB-202). https://www.lgcstandards-atcc.org/products/all/TIB-202.aspx. Accessed 4 Jan 2018.
Seifert K, Escobar P, Croft SL (2010) In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. J Antimicrob Chemother 65(3):508–511. https://doi.org/10.1093/jac/dkp500
Sereno D, Lemesre JL (1997) Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother 41(5):972–976
Aldo PB, Craveiro V, Guller S, Mor G (2013) Effect of culture conditions on the phenotype of THP-1 monocyte cell line. Am J Reprod Immunol 70(1):80–86. https://doi.org/10.1111/aji.12129
Wenger SL, Senft JR, Sargent LM, Bamezai R, Bairwa N, Grant SG (2004) Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci Rep 24(6):631–639. https://doi.org/10.1007/s10540-005-2797-5
Briske-Anderson MJ, Finley JW, Newman SM (1997) The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med 214(3):248–257
Moreira D, Santarem N, Loureiro I, Tavares J, Silva AM, Amorim AM, Ouaissi A, Cordeiro-da-Silva A, Silvestre R (2012) Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Negl Trop Dis 6(1):e1469. https://doi.org/10.1371/journal.pntd.0001469
Ali KS, Rees RC, Terrell-Nield C, Ali SA (2013) Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana. Parasite Immunol 35(12):441–456. https://doi.org/10.1111/pim.12056
Acknowledgments
This work was supported by funds from the Fundação para a Ciência e Tecnologia (FCT)/Ministério da Educação e Ciência (MEC) cofunded by the European Regional Development Fund (FEDER) under the Partnership agreement PT2020, through the Research Unit No.4293. This work also received funds from project POCI-01-0145-FEDER-031013 financed by Portugal 2020, under the Programa Operacional Competitividade e Internacionalização (COMPETE 2020) and Norte-01-0145-FEDER-000012—Structured program on bioengineered therapies for infectious diseases and tissue regeneration, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the FEDER. J.T. is an Investigator FCT funded by National funds through FCT and cofunded through European Social Fund within the Human Potential Operating Programme.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Santarém, N., Tavares, J., Cordeiro-da-Silva, A. (2019). In Vitro Infections of Macrophage-Like Cell Lines with Leishmania infantum for Drug Screening. In: Clos, J. (eds) Leishmania. Methods in Molecular Biology, vol 1971. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9210-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9210-2_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9209-6
Online ISBN: 978-1-4939-9210-2
eBook Packages: Springer Protocols